CAW
IONS icon

Cornerstone Advisors (Washington)’s Ionis Pharmaceuticals IONS Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$33K Sell
685
-27
-4% -$1.5K ﹤0.01% 319
2020
Q2 		$42K Buy
712
+49
+7% +$2.73K ﹤0.01% 282
2020
Q1 		$31K Buy
663
+343
+107% +$19.1K ﹤0.01% 282
2019
Q4 		$19K Buy
320
+13
+4% +$775 ﹤0.01% 352
2019
Q3 		$18K Buy
307
+56
+22% +$3.65K ﹤0.01% 346
2019
Q2 		$16K Sell
251
-28
-10% -$1.98K ﹤0.01% 678
2019
Q1 		$23K Buy
279
+28
+11% +$1.81K ﹤0.01% 577
2018
Q4 		$14K Sell
251
-467
-65% -$23.8K ﹤0.01% 575
2018
Q3 		$37K Hold
718
– – 0.02% 384
2018
Q2 		$30K Hold
718
– – 0.02% 420
2018
Q1 		$32K Hold
718
– – 0.02% 394
2017
Q4 		$36K Hold
718
– – 0.02% 345
2017
Q3 		$36K Sell
718
-192
-21% -$10.1K 0.02% 329
2017
Q2 		$46K Hold
910
– – 0.03% 294
2017
Q1 		$37K Hold
910
– – 0.02% 331
2016
Q4 		$44K Hold
910
– – 0.04% 284
2016
Q3 		$33K Sell
910
-200
-18% -$6.26K 0.03% 338
2016
Q2 		$26K Hold
1,110
– – 0.03% 238
2016
Q1 		$45K Hold
1,110
– – 0.05% 167
2015
Q4 		$69K Sell
1,110
-13
-1% -$701 0.08% 141
2015
Q3 		$45K Buy
+1,123
New +$58.1K 0.04% 189

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Cornerstone Advisors (Washington)'s IONS Position: Q3 2020 in Review

Cornerstone Advisors (Washington) reduced its Ionis Pharmaceuticals (IONS) stake by 3.8% in Q3 2020, selling an estimated $1.5K and leaving 685 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #319.

Cornerstone Advisors (Washington) first reported a position in IONS in Q3 2015 and has held it in 21 quarters since. The position peaked at $69K in Q4 2015. 368 funds tracked by Wall St. Rank hold IONS as of Q3 2020.

  • Cornerstone Advisors (Washington) held 685 shares of Ionis Pharmaceuticals worth $33K as of Q3 2020.
  • Cornerstone Advisors (Washington) sold 27 Ionis Pharmaceuticals shares in Q3 2020, an estimated $1.5K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #319 holding.
  • Cornerstone Advisors (Washington) first reported a position in Ionis Pharmaceuticals in Q3 2015 and has held it in 21 quarters since.
  • Cornerstone Advisors (Washington)'s Ionis Pharmaceuticals position peaked at $69K in Q4 2015.
  • 368 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.